JPH11508914A5 - - Google Patents

Info

Publication number: JPH11508914A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP1997505748A

Other languages

English (en)

Japanese (ja)

Other versions

JP4084415B2 (ja

JPH11508914A (ja

Filing date

1996-07-04

Publication date

2004-08-05

1995-07-11 Priority claimed from GBGB9514074.5A external-priority patent/GB9514074D0/en

1995-10-05 Priority claimed from GBGB9520311.3A external-priority patent/GB9520311D0/en

1995-11-08 Priority claimed from GBGB9522837.5A external-priority patent/GB9522837D0/en

1996-07-04 Application filed filed Critical

1996-07-04 Priority claimed from PCT/SE1996/000911 external-priority patent/WO1997003084A1/en

1999-08-03 Publication of JPH11508914A publication Critical patent/JPH11508914A/ja

2004-08-05 Publication of JPH11508914A5 publication Critical patent/JPH11508914A5/ja

2008-04-30 Application granted granted Critical

2008-04-30 Publication of JP4084415B2 publication Critical patent/JP4084415B2/ja

2016-07-04 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

JP50574897A 1995-07-11 1996-07-04 新しい血小板凝集抑制剤 Expired - Fee Related JP4084415B2 (ja)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
GBGB9514074.5A GB9514074D0 (en)	1995-07-11	1995-07-11	Compounds
GB9514074.5		1995-07-11
GB9520311.3		1995-10-05
GBGB9520311.3A GB9520311D0 (en)	1995-10-05	1995-10-05	Compounds
GBGB9522837.5A GB9522837D0 (en)	1995-11-08	1995-11-08	Compounds
GB9522837.5		1995-11-08
PCT/SE1996/000911 WO1997003084A1 (en)	1995-07-11	1996-07-04	New inhibitors of platelet aggregation

Publications (3)

Publication Number	Publication Date
JPH11508914A JPH11508914A (ja)	1999-08-03
JPH11508914A5 true JPH11508914A5 (2)	2004-08-05
JP4084415B2 JP4084415B2 (ja)	2008-04-30

Family

ID=27267806

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP50574897A Expired - Fee Related JP4084415B2 (ja)	1995-07-11	1996-07-04	新しい血小板凝集抑制剤

Country Status (25)

Country	Link
US (1)	US5747496A (2)
EP (1)	EP0840740B1 (2)
JP (1)	JP4084415B2 (2)
KR (1)	KR100444123B1 (2)
CN (1)	CN1069321C (2)
AR (1)	AR003453A1 (2)
AT (1)	ATE217010T1 (2)
AU (1)	AU699034B2 (2)
BR (1)	BR9609467A (2)
CA (1)	CA2226758A1 (2)
CZ (1)	CZ297200B6 (2)
DE (1)	DE69621021T2 (2)
EE (1)	EE03616B1 (2)
HU (1)	HU221880B1 (2)
IL (1)	IL122814A (2)
IS (1)	IS1790B (2)
MY (1)	MY116542A (2)
NO (1)	NO310624B1 (2)
NZ (1)	NZ312258A (2)
PL (1)	PL182680B1 (2)
SA (1)	SA96170272B1 (2)
SK (1)	SK283206B6 (2)
TR (1)	TR199800019T1 (2)
TW (1)	TW427996B (2)
WO (1)	WO1997003084A1 (2)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0946561B1 (en) *	1996-12-20	2002-02-13	AstraZeneca AB	Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
SE9702772D0 (sv) *	1997-07-22	1997-07-22	Astra Pharma Prod	Novel compounds
SE9702773D0 (sv)	1997-07-22	1997-07-22	Astra Pharma Prod	Novel compounds
SE9702774D0 (sv) *	1997-07-22	1997-07-22	Astra Pharma Prod	Novel compounds
AR017014A1 (es) *	1997-07-22	2001-08-22	Astrazeneca Ab	Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
NZ505250A (en) *	1998-02-17	2002-10-25	Astrazeneca Uk Ltd	Novel triazolo(4,5-d) pyrimidine compounds and pharmaceuticals thereof.
SE9802574D0 (sv) *	1998-07-17	1998-07-17	Astra Pharma Prod	Novel compounds
TWI229674B (en) *	1998-12-04	2005-03-21	Astra Pharma Prod	Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
SE9904128D0 (sv) *	1999-11-15	1999-11-15	Astra Pharma Prod	Novel compounds
SE9904129D0 (sv)	1999-11-15	1999-11-15	Astra Pharma Prod	Novel compounds
SE9904377D0 (sv) *	1999-12-01	1999-12-01	Astra Pharma Prod	Pharmaceutical combinations
GB0013488D0 (en) *	2000-06-02	2000-07-26	Astrazeneca Ab	Chemical compound
GB0013407D0 (en) *	2000-06-02	2000-07-26	Astrazeneca Ab	Forms of a chemical compound
US7132408B2 (en)	2000-08-21	2006-11-07	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
AR039558A1 (es) *	2000-08-21	2005-02-23	Inspire Pharmaceuticals Inc	Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US7018985B1 (en)	2000-08-21	2006-03-28	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
US7115585B2 (en) *	2000-08-21	2006-10-03	Inspire Pharmaceuticals, Inc.	Compositions for treating epithelial and retinal tissue diseases
US7452870B2 (en) *	2000-08-21	2008-11-18	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with P2Y12 receptor antagonist compound
US6897201B2 (en)	2000-08-21	2005-05-24	Inspire Pharmaceuticals, Inc.	Compositions and methods for the treatment of glaucoma or ocular hypertension
GB0100624D0 (en) *	2001-01-10	2001-02-21	Vernalis Res Ltd	Chemical compounds VII
SE0101932D0 (sv) *	2001-05-31	2001-05-31	Astrazeneca Ab	Pharmaceutical combinations
US20020169730A1 (en) *	2001-08-29	2002-11-14	Emmanuel Lazaridis	Methods for classifying objects and identifying latent classes
US7435724B2 (en)	2002-02-27	2008-10-14	Inspire Pharmaceutical, Inc.	Degradation-resistant mononucleoside phosphate compounds
EP1618108A2 (en) *	2003-04-09	2006-01-25	Biogen Idec MA Inc.	Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosine receptor antagonists
US7674791B2 (en) *	2003-04-09	2010-03-09	Biogen Idec Ma Inc.	Triazolopyrazines and methods of making and using the same
EP1615930A2 (en) *	2003-04-09	2006-01-18	Biogen Idec MA, Inc.	Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagonists
US20070010522A1 (en) *	2003-04-09	2007-01-11	Chi Vu	Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists
WO2004092173A2 (en) *	2003-04-09	2004-10-28	Biogen Idec Ma Inc.	A2a adenosine receptor antagonists
US7504497B2 (en) *	2003-10-21	2009-03-17	Inspire Pharmaceuticals, Inc.	Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) *	2003-10-21	2010-07-06	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
AU2004284098B2 (en) *	2003-10-21	2009-07-16	Inspire Pharmaceuticals, Inc.	Tetrahydro-furo [3,4-d] dioxole compounds and compositions and method for inhibiting platelet aggregation
US7335648B2 (en) *	2003-10-21	2008-02-26	Inspire Pharmaceuticals, Inc.	Non-nucleotide composition and method for inhibiting platelet aggregation
GB2422782A (en) *	2003-10-21	2006-08-09	Inspire Pharmaceuticals Inc	Non-nucleotide compositions and method for treating pain
US7932376B2 (en) *	2005-05-05	2011-04-26	Inspire Pharmaceuticals, Inc.	Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JP2010508350A (ja) *	2006-10-31	2010-03-18	ヤンセンファーマシューティカエヌ．ベー．	Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体
UA100864C2 (uk) *	2007-12-03	2013-02-11	Астразенека Аб	Спосіб лікування або запобігання аневризмі черевної аорти
GB0906579D0 (en) *	2009-04-16	2009-05-20	Vernalis R&D Ltd	Pharmaceuticals, compositions and methods of making and using the same
US8470834B2 (en) *	2008-08-20	2013-06-25	Merck Sharp & Dohme Corp.	AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2788072A1 (en)	2010-02-16	2011-08-25	Actavis Group Ptc Ehf	Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
MX2014006190A (es)	2011-11-30	2014-07-10	Actavis Group Ptc Ehf	Nueva forma cristalina de ticagrelor y proceso para la preparacion de la misma.
WO2014083139A1 (en)	2012-11-29	2014-06-05	Actavis Group Ptc Ehf	Novel amorphous form of ticagrelor
WO2014206187A1 (zh)	2013-06-24	2014-12-31	苏州明锐医药科技有限公司	替卡格雷及其中间体的制备方法
JP6145574B2 (ja) *	2013-06-27	2017-06-14	スーヂョウミラクファーマテクノロジカンパニーリミテッドＳｕｚｈｏｕＭｉｒａｃｐｈａｒｍａＴｅｃｈｎｏｌｏｇｙＣｏ．，Ｌｔｄ．	チカグレロールの調製方法
CN105061431B (zh) *	2015-07-28	2017-03-29	山东百诺医药股份有限公司	6‑n‑（2‑（甲硫基）乙基）‑2‑（（3,3,3‑三氟丙基）硫代）‑9h‑嘌呤及其制备方法和应用
CN112915063B (zh) *	2021-01-25	2022-12-20	刘红枚	一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物
CN112876485A (zh) *	2021-01-25	2021-06-01	郭丽伟	一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物
RU2770405C1 (ru) *	2021-07-05	2022-04-15	федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации	Производные триазола, проявляющие антиагрегационную активность

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4742064A (en) *	1985-09-10	1988-05-03	Regents Of The University Of Minnesota	Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) *	1988-11-09	1988-12-14	Wellcome Found	Heterocyclic compounds
JP2619710B2 (ja) *	1989-02-27	1997-06-11	日本製紙株式会社	２′，３′−ジデオキシプリンヌクレオシド類の製造方法
EP0684953A4 (en) *	1993-02-03	1999-12-22	Gensia Inc	ADENOSINE KINASE INHIBITORS COMPRISING LYXOFURANOSYL DERIVATIVES.
IL108523A0 (en) *	1993-02-03	1994-05-30	Gensia Inc	Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain

1996
- 1996-07-04 TR TR1998/00019T patent/TR199800019T1/xx unknown
- 1996-07-04 WO PCT/SE1996/000911 patent/WO1997003084A1/en not_active Ceased
- 1996-07-04 BR BR9609467A patent/BR9609467A/pt active Search and Examination
- 1996-07-04 US US08/737,005 patent/US5747496A/en not_active Expired - Fee Related
- 1996-07-04 SK SK23-98A patent/SK283206B6/sk unknown
- 1996-07-04 CN CN96196720A patent/CN1069321C/zh not_active Expired - Fee Related
- 1996-07-04 TW TW085108062A patent/TW427996B/zh not_active IP Right Cessation
- 1996-07-04 DE DE69621021T patent/DE69621021T2/de not_active Expired - Fee Related
- 1996-07-04 KR KR10-1998-0700187A patent/KR100444123B1/ko not_active Expired - Fee Related
- 1996-07-04 CA CA002226758A patent/CA2226758A1/en not_active Abandoned
- 1996-07-04 IL IL12281496A patent/IL122814A/en not_active IP Right Cessation
- 1996-07-04 NZ NZ312258A patent/NZ312258A/xx unknown
- 1996-07-04 EE EE9800026A patent/EE03616B1/xx not_active IP Right Cessation
- 1996-07-04 EP EP96923160A patent/EP0840740B1/en not_active Expired - Lifetime
- 1996-07-04 HU HU9802448A patent/HU221880B1/hu active IP Right Grant
- 1996-07-04 PL PL96324396A patent/PL182680B1/pl not_active IP Right Cessation
- 1996-07-04 CZ CZ0002598A patent/CZ297200B6/cs not_active IP Right Cessation
- 1996-07-04 AT AT96923160T patent/ATE217010T1/de not_active IP Right Cessation
- 1996-07-04 AU AU63751/96A patent/AU699034B2/en not_active Ceased
- 1996-07-04 JP JP50574897A patent/JP4084415B2/ja not_active Expired - Fee Related
- 1996-07-11 MY MYPI96002866A patent/MY116542A/en unknown
- 1996-07-11 AR ARP960103538A patent/AR003453A1/es active IP Right Grant
- 1996-08-28 SA SA96170272A patent/SA96170272B1/ar unknown
1998
- 1998-01-08 NO NO19980080A patent/NO310624B1/no unknown
- 1998-01-08 IS IS4647A patent/IS1790B/is unknown

Publication	Publication Date	Title
JP2000500228A5 (2)	2004-09-09
JP2000516406A5 (2)	2004-11-04
JP2000500327A5 (2)	2005-10-06
JPH11512433A5 (2)	2004-10-21
JPH11508770A5 (2)	2004-08-05
JPH11512306A5 (2)	2004-09-24
JP2000500145A5 (2)	2004-10-14
JP2000500155A5 (2)	2004-10-21
JP2000500406A5 (2)	2004-10-14
JPH11513809A5 (2)	2004-07-15
JPH11512038A5 (2)	2004-09-24
JP2000500361A5 (2)	2004-10-14
JPH11514843A5 (2)	2004-07-22
JP2000500115A5 (2)	2004-07-08
JP2000500322A5 (2)	2004-09-30
JP2000500258A5 (2)	2004-08-12
JP2000500342A5 (2)	2004-10-21
JPH11508914A5 (2)	2004-08-05
JP2000500192A5 (2)	2004-07-15
JP2000500112A5 (2)	2004-10-14
JP2000500226A5 (2)	2004-08-12
JP2000500407A5 (2)	2004-10-21
JP2000500397A5 (2)	2004-10-21
JP2000500166A5 (2)	2004-09-24
JP2000500125A5 (2)	2004-10-21